Identification and functional characterization of Penicillium marneffei major facilitator superfamily (MFS) transporters

References

• Houbraken J, de Vries RP, Samson RA Modern taxonomy of biotechnologically important aspergillus and penicillium species [Internet]. 1st ed. Vol. 86. In: Advances in Applied Microbiology. Copyright © 2014 Elsevier Inc. All rights reserved; 2014. 199–249 p. doi: 10.1016/B978-0-12-800262-9.00004-4
   Google Scholar
• Vanittanakom N, Cooper CR, Fisher MC, et al. Penicillium marneffei infection and recent advances in the epidemiology and molecular biology aspects. Clin Microbiol Rev. 2006;19(1):95–110.
   PubMed Web of Science ®Google Scholar
• Chan JFW, Lau SKP, Yuen KY, et al. Talaromyces (Penicillium) marneffei infection in non-HIV-infected patients. Emerg Microbes Infect [ Internet]. 2016;5(3):1–9.
   Google Scholar
• Wong SYN, Wong KF. Penicillium marneffei infection in AIDS. Path Research Int. 2011;2011(Figure 3):12–20.
   Google Scholar
• Kawila R, Chaiwarith R, Supparatpinyo K. Clinical and laboratory characteristics of penicilliosis marneffei among patients with and without HIV infection in Northern Thailand: A retrospective study. BMC Infect Dis. 2013;13(1):1–5.
   PubMed Web of Science ®Google Scholar
• Sar B, Boy S, Keo C, et al. In vitro antifungal-drug susceptibilities of mycelial and yeast forms of Penicillium marneffei isolates in Cambodia. J Clin Microbiol. 2006;44(11):4208–4210.
   PubMed Web of Science ®Google Scholar
• Hu Y, Zhang J, Li X, et al. Penicillium marneffei infection: an emerging disease in Mainland China. Mycopathologia. 2013;175(1–2):57–67.
   PubMed Web of Science ®Google Scholar
• Le T, Kinh NV, Cuc NTK, et al. A trial of itraconazole or amphotericin B for HIV-associated talaromycosis. N Engl J Med. 2017;376(24):2329–2340.
   PubMed Web of Science ®Google Scholar
• Supparatpinyo K, Schlamm HT. Voriconazole as therapy for Systemic Penicillium marneffei infections in AIDS patients. Am J Trop Med Hyg. 2007;77(2):350–353.
   PubMed Web of Science ®Google Scholar
• Gulshan K, Moye-Rowley WS. Multidrug resistance in fungi. Eukaryot Cell. 2007;6(11):1933–1942.
   PubMedGoogle Scholar
• Pao SS, Paulsen IT, Saier MH. Major facilitator superfamily . Microbiol Mol Biol Rev [Internet]. 1998;62(1):1–34. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9529885%0Ahttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC98904.
   PubMed Web of Science ®Google Scholar
• Tanabe K, Lamping E, Nagi M, et al. Chimeras of Candida albicans Cdr1p and Cdr2p reveal features of pleiotropic drug resistance transporter structure and function. Mol Microbiol. 2011;82(2):416–433.
   PubMed Web of Science ®Google Scholar
• Holmes AR, Lin YH, Niimi K, et al. ABC transporter Cdr1p contributes more than Cdr2p does to fluconazole efflux in fluconazole-resistant Candida albicans clinical isolates. Antimicrob Agents Chemother. 2008;52(11):3851–3862.
   PubMed Web of Science ®Google Scholar
• Tsao S, Rahkhoodaee F, Raymond M. Relative contributions of the Candida albicans ABC transporters Cdr1p and Cdr2p to clinical azole resistance. Antimicrob Agents Chemother. 2009;53(4):1344–1352.
   PubMed Web of Science ®Google Scholar
• Nakamura K, Niimi M, Niimi K, et al. Functional expression of candida albicans drug efflux pump Cdr1p in a saccharomyces cerevisiae strain deficient in membrane transporters. Antimicrob Agents Chemother. 2001;45(12):3366–3374.
   PubMed Web of Science ®Google Scholar
• Sanglard D, Ischer F, Calabrese D, et al. The ATP binding cassette transporter gene CgCDR1 from candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents. Antimicrob Agents Chemother. 1999;43(11):2753–2765.
   PubMed Web of Science ®Google Scholar
• Posteraro B, Sanguinetti M, Sanglard D, et al. Identification and characterization of a Cryptococcus neoformans ATP binding cassette (ABC) transporter- encoding gene, CnAFR1, involved in the resistance to fluconazole. Mol Microbiol. 2003;47:357–371.
   PubMed Web of Science ®Google Scholar
• Panapruksachat S, Iwatani S, Oura T, et al. Identification and functional characterization of Penicillium marneffei pleiotropic drug resistance transporters ABC1 and ABC2. Med Mycol. 2016;54(5):478–491.
   PubMed Web of Science ®Google Scholar
• Saier MH, Reddy VS, Tsu BV, et al. The Transporter Classification Database (TCDB): recent advances. Nucleic Acids Res. 2016;44(D1):D372–9.
   PubMed Web of Science ®Google Scholar
• Paulsen IT, Brown MH, Skurray RA. Proton-dependent multidrug efflux systems . Microbiol Rev [Internet]. 1996;60(4):575–608. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8987357%0Ahttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC239457.
   PubMedGoogle Scholar
• Tomitori H, Kashiwagi K, Sakata K, et al. Identification of a gene for a polyamine transport protein in yeast. J Bio Chem. 1999;274:3265–3268.
   PubMed Web of Science ®Google Scholar
• Tomitori H, Kashiwagi K, Asakawa T, et al. Multiple polyamine transport systems on the vacuolar membrane in yeast. Biochem J. 2001;353:681–688.
   PubMed Web of Science ®Google Scholar
• Vargas RC, Tenreiro S, Teixeira MC, et al. Saccharomyces cerevisiae multidrug transporter Qdr2p (Yil121wp): localization and function as a quinidine resistance determinant. Antimicrob Agents Chemother. 2004;48(7):2531–2537.
   PubMed Web of Science ®Google Scholar
• Teixeira MC, Cabrito TR, Hanif ZM, et al. Yeast response and tolerance to polyamine toxicity involving the drug: H + antiporter Qdr3 and the transcription factors Yap1 and Gcn4. Microbiology. 2010;157(4):945–956.
   PubMedGoogle Scholar
• Nunes PA, Tenreiro S, Sá-Correia I. Resistance and adaptation to quinidine in saccharomyces cerevisiae: role of QDR1 (YIL120w), encoding a plasma membrane transporter of the major facilitator superfamily required for multidrug. Antimicrob Agents Chemother [ Internet]. 2001 May 1;45(5):1528LP– 1534. Available from: http://aac.asm.org/content/45/5/1528.abstract
   Web of Science ®Google Scholar
• Velasco I, Tenreiro S, Calderon IL, et al. Saccharomyces cerevisiae Aqr1 Is an internal-membrane transporter involved in excretion of amino acids. Eukaryot Cell [Internet]. 2004 Dec 1;3(6):1492LP– 1503. Available from: http://ec.asm.org/content/3/6/1492.abstract
   Google Scholar
• Felder T, Bogengruber E, Tenreiro S, et al. Dtr1p, a multidrug resistance transporter of the major facilitator superfamily, plays an essential role in spore wall maturation in saccharomyces cerevisiae. Eukaryot Cell [Internet]. 2002 Oct 1;1(5):799 LP– 810. Available from: http://ec.asm.org/content/1/5/799.abstract
   Google Scholar
• Gaber RF, Kielland-Brandt MC, Fink GR. HOL1 mutations confer novel ion transport in Saccharomyces cerevisiae. Mol Cell Biol [Internet]. 1990 Feb 1;10(2):643 LP– 652. Available from: http://mcb.asm.org/content/10/2/643.abstract
   Web of Science ®Google Scholar
• Nguye D, Alarco A, Raymond M. Multiple Yap1p-binding sites mediate induction of the yeast major facilitator FLR1 gene in response to drugs, oxidants, and alkylating agents. J Biol Chem. 2001;276(2):1138–1145.
   PubMed Web of Science ®Google Scholar
• Barker KS, Pearson MM, Rogers PD. Original articles Identification of genes differentially expressed in association with reduced azole susceptibility in Saccharomyces cerevisiae. J Antimicrob Chemother. 2003 Apr; 51(5):1131–1140.
   PubMed Web of Science ®Google Scholar
• Calabrese D, Sanglard D, Bille J. A novel multidrug efflux transporter gene of the major facilitator superfamily from Candida albicans (FLU1) conferring resistance to fluconazole. Microbiology. 2015;146(11):2743–2754.
   Google Scholar
• Yamada-Okabe T, Yamada-Okabe H. Characterization of the CaNAG3, CaNAG4, and CaNAG6 genes of the pathogenic fungus Candida albicans: possible involvement of these genes in the susceptibilities of cytotoxic agents. FEMS Microbiol Lett. 2002;212(1):15–21.
   PubMed Web of Science ®Google Scholar
• Shah AH, Singh A, Dhamgaye S, et al. Novel role of a family of major facilitator transporters in biofilm development and virulence of Candida albicans. Biochem J [Internet]. 2014 May 13;460(2):223–235.
   PubMedGoogle Scholar
• Costa C, Henriques A, Pires C, et al. The dual role of Candida glabrata drug: H+ antiporter CgAqr1 (ORF CAGL0J09944g) in antifungal drug and acetic acid resistance. Front Microbiol. 2013 Jun;4: 1–13.
   PubMed Web of Science ®Google Scholar
• Costa C, Nunes J, Henriques A, et al. Candida glabrata drug: H+antiporter CgTpo3 (ORF CAGL0I10384G): role in azole drug resistance and polyamine homeostasis. J Antimicrob Chemother. 2014;69(7):1767–1776.
   PubMed Web of Science ®Google Scholar
• Costa C, Pires C, Cabrito TR, et al. Candida glabrata drug: H+ antiporter CgQdr2 confers imidazole drug resistance, being activated by transcription factor CgPdr1. Antimicrob Agents Chemother. 2013;57(7):3159–3167.
   PubMed Web of Science ®Google Scholar
• Pais P, Pires C, Costa C, et al. Membrane proteomics analysis of the Candida glabrata response to 5-flucytosine : unveiling the role and regulation of the drug efflux transporters CgFlr1 and CgFlr2 strains and growth media. Front Microbiol. 2016 Dec;7:1–14.
   PubMed Web of Science ®Google Scholar
• Costa C, Dias PJ, Sá-Correia I, et al. MFS multidrug transporters in pathogenic fungi: do they have real clinical impact? Front Physiol. 2014 May; 5:1–8.
   PubMed Web of Science ®Google Scholar
• Lamping E, Monk BC, Niimi K, et al. Characterization of three classes of membrane proteins involved in fungal azole resistance by functional hyperexpression in saccharomyces cerevisiae. Eukaryotic Cell. 2007;6(7):1150–1165.
   PubMedGoogle Scholar
• Mcginnis S, Madden TL. at the core of a powerful and diverse set of sequence analysis tools. Blast . 2004;32:20–25.
   Google Scholar
• Sievers F, Higgins DG. Clustal Omega for making accurate alignments of many protein sequences. Protein Sci. 2018;27:135–145.
   PubMed Web of Science ®Google Scholar
• Furusawa H, Miyazaki Y, Sonoda S, et al. Penicilliosis marneffei complicated with interstitial Pneumonia. Intern Med. 2014;53(4):321–323.
   PubMed Web of Science ®Google Scholar
• Lamping E, Ranchod A, Nakamura K, et al. Abc1p is a multidrug efflux transporter that tips the balance in favor of innate azole resistance in Candida krusei. Antimicrob Agents Chemother. 2009;53(2):354–369.
   PubMed Web of Science ®Google Scholar
• Maruyama T, Masuda N, Kakinuma Y, et al. Polyamine-sensitive magnesium transport in Saccharomyces cerevisiae. BBA - Biomembr. 1994;1194(2):289–295.
   PubMed Web of Science ®Google Scholar
• Cannon RD, Lamping E, Holmes AR, et al. Efflux-mediated antifungal drug resistance. Clin Microbiol Rev. 2009;22:291–321.
   PubMed Web of Science ®Google Scholar
• Griffith JK, Rouch A, Paulsen IT, et al. Membrane transport implications of sequence proteins: comparisons. Curr Opin Cell Biol. 1992;4:684–695.
   PubMedGoogle Scholar
• Kovalchuk A, Driessen AJM. Phylogenetic analysis of fungal ABC transporters. BMC Genomics. 2010;11:1.
   PubMed Web of Science ®Google Scholar
• Janbon G, Ormerod KL, Paulet D, et al. Analysis of the genome and transcriptome of cryptococcus neoformans var. grubii reveals complex RNA expression and microevolution leading to virulence attenuation. PLoS Genet. 2014;10:4.
   Web of Science ®Google Scholar
• Coleman JJ, Mylonakis E. Efflux in fungi: la pièce de résistance. PLoS Pathog. 2009;5:6.
   Web of Science ®Google Scholar
• Niimi M, Wada S, Tanabe K, et al. Functional analysis of fungal drug efflux transporters by heterologous expression in saccharomyces cerevisiae. Jpn J Infect Dis. 2005;58(1):1–7.
   Google Scholar
• Holmes AR, Tsao S, Ong S, et al. Heterozygosity and functional allelic variation in the Candida albicans efflux pump genes CDR1 and CDR2. Mol Microbiol. 2006 Aug; 62(1): 170–186.
   Google Scholar
• Nichols JW, de Wet H, McIntosh DB, et al. ATPase and multidrug transport activities of the overexpressed yeast ABC protein Yor1p. J Biol Chem. 2002;273(20):12612–12622.
   Google Scholar
• Sá-Correia I, Dos Santos SC, Teixeira MC, et al. Drug:H+antiporters in chemical stress response in yeast. Trends Microbiol. 2009;17(1):22–31.
   PubMed Web of Science ®Google Scholar